Home

William D. Humphries

CIK 1674278 · President, Ortho-Dermatologics · last filed 2026-06-08

William D. Humphries is a President, Ortho-Dermatologics who has filed 48 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for ACRS, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.30M

Companies

5

Total Filings

48

Lifetime Open-Market Net

-$2.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACRS Director 45,105 $5.33 $240.4K $0 13 2026-06-08
Clearside Biomedical, Inc. (CLSD) Delisted Director 3,403 $0.35 $1.2K $9.9K 12 2024-06-21
STRATA Skin Sciences, Inc. (SSKN) Delisted Director 10,972 $0.15 $1.6K $52.8K 5 2023-07-07
PhaseBio Pharmaceuticals Inc (PHAS) Delisted Director — $0.07 — $0 3 2022-06-10
BHC President, Ortho-Dermatologics 235,035 $4.52 $1.06M -$2.43M 11 2020-12-08

Recent Filings

48 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-08 ACRS Mixed +11,580 $0 EDGAR
2025-06-09 ACRS Mixed +4,793 $0 EDGAR
2024-06-21 Clearside Biomedical, Inc. (CLSD) Delisted Grant (A) — $0 EDGAR
2024-06-10 ACRS Grant (A) — $0 EDGAR
2024-06-04 ACRS Exer (M) +4,660 $0 EDGAR
2023-09-22 Clearside Biomedical, Inc. (CLSD) Delisted Exer (M) +22,727 $9.1K EDGAR
2023-07-07 STRATA Skin Sciences, Inc. (SSKN) Delisted Grant (A) +36,408 $37.5K EDGAR
2023-06-23 Clearside Biomedical, Inc. (CLSD) Delisted Grant (A) — $0 EDGAR
2023-06-05 ACRS Mixed +4,507 $0 EDGAR
2023-05-19 — Exer (M) +2,538 $0
Showing 1–10 of 48
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.